From: Definitive radiotherapy for early stage glottic cancer by 6 MV photons
Author (year) | Patient number | Local Control (%) | OS (%) | CSS (%) |
---|---|---|---|---|
[ref] | 5 year*, 10 year # | 5 year *, 10 year# | 5 year*, 10 year# | |
Warde et al. [5] | T1 + T2: 72 | T1a: 91* | T1 + T2: 75.8* | NA |
T1b: 82* | ||||
T2: 69* | ||||
Lee et al. [18] | T1: 86 | T1a: 82.2* | T1: 85* | NA |
T2: 29 | T1b: 76.2* | T2: 74* | ||
T2: 68.1* | ||||
Franchin et al. [23] | T1: 323 | T1: 90# | T1: 66# | NA |
T2: 87 | T2: 78# | T2: 55# | ||
T1: 35 | T1: 84*, 83# | T1: 77*, 57# | T1: 95*, 93# | |
T2: 68 | T2: 73*, 70# | T2: 59*, 37# | T2: 89*, 86# | |
Chera et al. [8] | T1 + T2: 23 | T1a: 94*, 93# | T1 a: 82*, 62# | T1a: 97*, 97# |
T1b: 93*, 91# | T1b: 83*, 57# | T1b: 99*, 95# | ||
T2a: 80*, 80# | T2a: 76*, 51# | T2a: 94*, 93# | ||
T2b: 70*, 67# | T2b: 78*, 49# | T2b: 90*, 84# | ||
Current series | T1: 433 | T1a: 92*, 91# | T1: 89*, 74# | T1: 98*, 97# |
T1b: 89*, 87# | T2: 89*, 70# | T2: 98*, 97# | ||
T2: 262 | T2: 79*, 77# |